J Neurocrit Care.  2017 Jun;10(1):7-12. 10.18700/jnc.170010.

Cardiac Complications in Patients Admitted to the Neuro-Intensive Care Unit

• Lee DH

• KMID: 2385880
• DOI: http://doi.org/10.18700/jnc.170010

Abstract

Patients admitted to the neuro-intensive care unit experience a number of cardiovascular complications. This is because of common risk factors exist between neurologic and cardiovascular diseases, and also the close interconnection between brain and heart, leading to an increased cardiovascular burden. Although the cardiovascular complications may or may not be clinically significant, the medical team should be aware of these instances, since such cardiac complications often result in fatal and irreversible outcomes. Particularly, unexpected cardiac arrest, acute myocardial infarction, uncontrolled atrial fibrillation, QT prolongation, and Takotsubo cardiomyopathy are common occurrences in the neuro-intensive care unit, and require careful attention. In this article, we review the incidence, clinical significance and management of such neuro-intensive care unit cardiac complications.

Keyword

Intensive care unit; Neuro-intensive care unit; Complication; Sudden cardiac death; Takotsubo cardiomyopathy

MeSH Terms

Atrial Fibrillation
Brain
Cardiovascular Diseases
Death, Sudden, Cardiac
Heart
Heart Arrest
Humans
Incidence
Intensive Care Units
Myocardial Infarction
Risk Factors
Takotsubo Cardiomyopathy

Reference

1. Nam GB. Cardiac arrhythmias in the intensive care units. J Neurocrit Care. 2014; 7:25–32.

2. Kim MS, Kim JJ. Heart and brain interconnection - clinical implications of changes in brain function during heart failure. Circ J. 2015; 79:942–7.

3. Sakamoto K, Saito T, Orman R, Koizumi K, Lazar J, Salciccioli L, et al. Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia. 2008; 49:982–96.

4. Shimizu M, Kagawa A, Takano T, Masai H, Miwa Y. Neurogenic stunned myocardium associated with status epileptics and postictal catecholamine surge. Intern Med. 2008; 47:269–73.

5. M Ramadan M, El-Shahat N, A Omar A, Gomaa M, Belal T, A Sakr S, et al. Interictal electrocardiographic and echocardiographic changes in patients with generalized tonic-clonic seizures. Int Heart J. 2013; 54:171–5.

6. Bealer SL, Little JG, Metcalf CS, Brewster AL, Anderson AE. Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus. Epilepsy Res. 2010; 91:66–73.

7. Nguyen-Michel VH, Adam C, Dinkelacker V, Pichit P, Boudali Y, Dupont S, et al. Characterization of seizure-induced syncopes: EEG, ECG, and clinical features. Epilepsia. 2014; 55:146–55.

8. Rincon F, Dhamoon M, Moon Y, Paik MC, Boden-Albala B, Homma S, et al. Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke. 2008; 39:2425–31.

9. Simula S, Muuronen AT, Taina M, Jäkälä P, Sipola P, Vanninen R, et al. Effect of middle cerebral artery territory ischemic stroke on QT interval. J Stroke Cerebrovasc Dis. 2014; 23:717–23.

10. Henninger N, Haussen DC, Kakouros N, Selim M, Searls DE, Kumar S, et al. QTc-prolongation in posterior circulation stroke. Neurocrit Care. 2013; 19:167–75.

11. Mathias CJ. Bradycardia and cardiac arrest during tracheal suction--mechanisms in tetraplegic patients. Eur J Intensive Care Med. 1976; 2:147–56.

12. Cardiac arrest during therapeutic tracheal suction. Anesth Analg. 1960; 39:568–9.

13. Winston SJ, Gravelyn TR, Sitrin RG. Prevention of bradycardic responses to endotracheal suctioning by prior administration of nebulized atropine. Crit Care Med. 1987; 15:1009–11.

14. Putaala J, Lehto M, Meretoja A, Silvennoinen K, Curtze S, Kääriäinen J, et al. In-hospital cardiac complications after intracerebral hemorrhage. Int J Stroke. 2014; 9:741–6.

15. Ahmadian A, Mizzi A, Banasiak M, Downes K, Camporesi EM, Thompson Sullebarger J, et al. Cardiac manifestations of subarachnoid hemorrhage. Heart Lung Vessel. 2013; 5:168–78.

16. Grunsfeld A, Fletcher JJ, Nathan BR. Cardiopulmonary complications of brain injury. Curr Neurol Neurosci Rep. 2005; 5:488–93.

17. Griffiths MJ, Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, et al. In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1β, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. J Infect Dis. 2012; 206:881–92.

18. Miranda RC, Machado MN, Takakura IT, da Mata PF, da Fonseca CG, Mouco OM, et al. Elevated troponin levels after prolonged supraventricular tachycardia in patient with normal coronary angiography. Cardiology. 2006; 106:10–3.

19. Mooe T, Eriksson P, Stegmayr B. Ischemic stroke after acute myocardial infarction. A population-based study. Stroke. 1997; 28:762–7.

20. Mathias TL, Albright KC, Boehme AK, Monlezun D, George AJ, Jones E, et al. The impact of myocardial infarction vs. pneumonia on outcome in acute ischemic stroke. J Cardiovasc Dis. 2014; 2:1–3.

21. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012; 126:e354–471.

22. Hocker S, Prasad A, Rabinstein AA. Cardiac injury in refractory status epilepticus. Epilepsia. 2013; 54:518–22.

23. Mukherjee S, Tripathi M, Chandra PS, Yadav R, Choudhary N, Sagar R, et al. Cardiovascular autonomic functions in wellcontrolled and intractable partial epilepsies. Epilepsy Res. 2009; 85:261–9.

24. Andrew NE, Thrift AG, Cadilhac DA. The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made? Neuroepidemiology. 2013; 40:227–39.

25. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37:2893–962.

26. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Kardiol Pol. 2016; 74:1359–469.

27. Nelson S, Leung J. QTc prolongation in the intensive care unit: a review of offending agents. AACN Adv Crit Care. 2011; 22:289–95. quiz 296-7.

28. Togha M, Sharifpour A, Ashraf H, Moghadam M, Sahraian MA. Electrocardiographic abnormalities in acute cerebrovascular events in patients with/without cardiovascular disease. Ann Indian Acad Neurol. 2013; 16:66–71.

29. Hjalmarsson C, Bergfeldt L, Bokemark L, Manhem K, Andersson B. Electrocardiographic abnormalities and elevated cTNT at admission for intracerebral hemorrhage: predictors for survival? Ann Noninvasive Electrocardiol. 2013; 18:441–9.

30. van der Bilt I, Hasan D, van den Brink R, Cramer MJ, van der Jagt M, van Kooten F, et al. Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome. Neurology. 2014; 82:351–8.

31. Link MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, Moitra VK, et al. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015; 132(18 Suppl 2):S444–64.

32. Soar J, Nolan JP, Böttiger BW, Perkins GD, Lott C, Carli P, et al. European Resuscitation Council guidelines for resuscitation 2015: section 3. adult advanced life support. Resuscitation. 2015; 95:100–47.

33. Lee SR, Yoon YE. Diagnosis and management of stressinduced cardiomyopathy in neurological intensive care units. J Neurocrit Care. 2015; 8:1–8.

34. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010; 55:333–41.

35. Kilbourn KJ, Levy S, Staff I, Kureshi I, McCullough L. Clinical characteristics and outcomes of neurogenic stress cadiomyopathy in aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2013; 115:909–14.

36. Rocha J, Gonçalves E, Vieira C, Almeida F, Pereira J. Takotsubo cardiomyopathy: a rare, but serious, complication of epileptic seizures. Arq Neuropsiquiatr. 2013; 71:195–7.

37. Yoshimura S, Toyoda K, Ohara T, Nagasawa H, Ohtani N, Kuwashiro T, et al. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol. 2008; 64:547–54.

38. Shiromoto T, Shibazaki K, Kimura K, Sakai K. Case of cerebellar hemorrhage complicated with takotsubo cardiomyopathy - usefulness of plasma brain natriutetic peptide measurement for the diagnosis. Rinsho Shinkeigaku. 2012; 52:778–81.

39. Kusaba T, Sasaki H, Sakurada T, Kuboshima S, Miura H, Okabayashi J, et al. Takotsubo cardiomyopathy thought to be induced by MRSA meningitis and cervical epidural abscess in a maintenance-hemodialysis patient: case report. Nihon Jinzo Gakkai Shi. 2004; 46:371–6.

40. Riera M, Llompart-Pou JA, Carrillo A, Blanco C. Head injury and inverted takotsubo cardiomyopathy. J Trauma. 2010; 68:E13–5.

41. Summers MR, Madhavan M, Chokka RG, Rabinstein AA, Prasad A. Coincidence of apical ballooning syndrome (takotsubo/stress cardiomyopathy) and posterior reversible encephalopathy syndrome: potential common substrate and pathophysiology? J Card Fail. 2012; 18:120–5.

42. Padayachee L. Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy? Heart Lung Circ. 2007; 16 Suppl 3:S65–70.

43. Santoro F, Ieva R, Ferraretti A, Ienco V, Carpagnano G, Lodispoto M, et al. Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series. Cardiovasc Ther. 2013; 31:e133–7.

44. Yaman M, Arslan U, Kaya A, Akyol A, Ozturk F, Okudan YE, et al. Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy. Cardiol J. 2016; 23:610–5.